Cargando…

Soft tissue handling and dental implant treatment

Detalles Bibliográficos
Autor principal:	Neukam, Friedrich Wilhelm
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3360344/ http://dx.doi.org/10.1186/1746-160X-8-S1-I7

Ejemplares similares

Strategies for handling missing data in randomised trials
por: White, Ian R
Publicado: (2011)

The Influence Of Topographical And Chemical Properties Of Dental Implants On Soft Tissue Integration
por: Ayukawa, Yasunori
Publicado: (2018)

Long-term results of implant-based functional rehabilitation of patients with ectodermal dysplasia
por: Reinert, Siegmar
Publicado: (2012)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

Large-scale identification of tissue-specific enhancers in vivo
por: Pennacchio, Len A
Publicado: (2010)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Treatment of oral dysfunction
por: McAllister, Anita
Publicado: (2012)

Treatment of MAS and HLH
por: Belot, Alexandre
Publicado: (2014)

The multimodal treatment in headaches
por: Lacerenza, Marco R, et al.
Publicado: (2015)

Prosthodontic treatment of patients with ectodermal dysplasia
por: Weber, Heiner
Publicado: (2012)

Hepatitis B: treatment strategies and resistance
por: Soriano, Vincent
Publicado: (2010)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

Treatment of septic arthritis and acute osteomyelitis
por: Peltola, Heikki
Publicado: (2014)

Treatments for persistent HIV infection: the road ahead
por: Margolis, David M
Publicado: (2010)

Oral tolerance induction protocols for treatment: an overview
por: Burks, Wesley
Publicado: (2011)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

Systematic review on treatment of juvenile idiopathic arthritis – associated uveitis
por: Heiligenhaus, Arnd
Publicado: (2014)

Current evidence for the medical treatments of systemic juvenile idiopathic arthritis
por: Ruperto, Nicolino
Publicado: (2014)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

Molecular mechanisms involved in HIV latency and implications for HIV treatment and eradication
por: Alcami, Jose, et al.
Publicado: (2010)

PReS13-SPK-1579: Biologic agents for the treatment of rheumatic diseases
por: Emery, P
Publicado: (2013)

Treatment of gastrointestinal complication in transthyretin amyloidosis. A single centre’s experience
por: Suhr, Ole B
Publicado: (2015)

Proposed requirements for hypoallergenic formulae to be used in the treatment and prevention of cow's milk allergy
por: Muraro, Antonella
Publicado: (2011)

Choosing the safest acute combination therapy during prophylactic treatment: pharmacokinetic and pharmacodynamic considerations
por: Lionetto, Luana, et al.
Publicado: (2015)

Hydrocephalus treatment and outcome in African infants with myelomeningocele: what we have learned so far
por: Warf, Benjamin C
Publicado: (2010)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

PReS13-SPK-1586: Biological agents for the treatment of rheumatic diseases: present and future targets of biologic therapy
por: Mcinnes, I
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-05. Development of fast cortical rhythms in health and mental disease
por: Hanganu-Opatz, Ileana
Publicado: (2022)

What happens after hepatitis C eradication?
por: Pol, Stanislas
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_gkaijdlg5lvoj5l78s1jr2non6